Literature DB >> 16302880

Symptomatic epilepsies imitating idiopathic generalized epilepsies.

Hirokazu Oguni1.   

Abstract

The diagnosis of idiopathic generalized epilepsies (IGEs) is not generally difficult if one follows the clinical and electroencephalogram (EEG) definitions of each subsyndrome that constitutes IGEs. In contrast, symptomatic epilepsies develop based on organic brain lesions and are easily diagnosed by the presence of developmental delay, neurologic abnormalities, and a characteristic seizure and EEG pattern. However, in clinical practice, it is sometimes difficult to differentiate IGEs from symptomatic epilepsies, especially when the clinical course from the onset of epilepsy is too short to exhibit typical clinical and EEG findings of either epilepsy type, or when patients with symptomatic epilepsies have atypical features that imitate the clinical characteristics of IGEs. The neurodegenerative or metabolic disorders at times start during the clinical course with epileptic seizures and later show typical neurologic abnormalities. The newly recognized metabolic disorder of glucose transporter type 1 deficiency syndrome (Glut-1 DS) may start with myoclonic seizures at an age of less than 1 year and imitate benign myoclonic epilepsy in infancy early in the clinical course. Progressive myoclonus epilepsies (PMEs) that develop at 1-4 years of age at times imitate epilepsy with myoclonic-astatic seizures with respect to the presence of astatic seizures and an epileptic encephalopathic EEG pattern. In addition, young children with focal cortical dysplasia may also have similar clinical and EEG patterns, although the latter may become localized after treatment. Approximately 15% of patients with juvenile myoclonic epilepsy (JME) are resistant to antiepileptic drugs (AEDs) and may require extensive study to make a differential diagnosis from symptomatic epilepsies. PMEs that develop during adolescence may imitate JME early in the clinical course; however, a detailed history and the differentiation between myoclonic seizures and myoclonus would help to distinguish both conditions. The diagnosis of IGEs is very demanding for patients with atypical features with regard to seizure type, EEG findings, and response to appropriate AEDs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302880     DOI: 10.1111/j.1528-1167.2005.00318.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  KBG syndrome mimicking genetic generalized epilepsy.

Authors:  M J Murphy; N McSweeney; G L Cavalleri; M T Greally; K A Benson; D J Costello
Journal:  Epilepsy Behav Rep       Date:  2022-04-20

2.  Clinical characteristics and aetiology of early childhood epilepsy: a single centre experience in Saudi Arabia.

Authors:  Noufa A Alonazi; Abdulrahman Alnemri; Ebtessam El Melegy; Noon Mohamed; Iman Talaat; Amany Hosny; Aisha Alonazi; Sarar Mohamed
Journal:  Sudan J Paediatr       Date:  2018

3.  Does Autoimmunity have a Role in Myoclonic Astatic Epilepsy? A Case Report of Voltage Gated Potassium Channel Mediated Seizures.

Authors:  Deepa Sirsi; Alison Dolce; Benjamin M Greenberg; Drew Thodeson
Journal:  Ann Clin Case Rep       Date:  2016-11-03

4.  Genetic generalized epilepsies with frontal lesions mimicking migratory disorders on the epilepsy monitoring unit.

Authors:  Susanne Fauser; Thomas Cloppenborg; Tilman Polster; Ulrich Specht; Friedrich G Woermann; Christian G Bien
Journal:  Epilepsia Open       Date:  2020-03-12

Review 5.  Symptomatic asymmetry in the first six months of life: differential diagnosis.

Authors:  Jacqueline Nuysink; Ingrid C van Haastert; Tim Takken; Paul J M Helders
Journal:  Eur J Pediatr       Date:  2008-03-04       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.